Tuberculosis News and Research

Latest Tuberculosis News and Research

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

Fungal infection causes around half of AIDS-related deaths, of which there were 1,100,000 in 2015. A first of its kind analysis – ‘Modelling reduction in AIDS deaths’ by the University of Manchester’s Professor David W Denning and published today in Philosophical Transactions of the Royal Society B – suggests that the opportunity to save lives is being missed.

25 Oct 2016

Two leading non-profit organizations sign strategic affiliation to hasten drug development

The Scripps Research Institute and the California Institute for Biomedical Research - two leading non-profit research organizations - today announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.

20 Oct 2016

Study estimates impact of six common healthcare-associated infections

A study published today by PLOS Medicine, estimates the combined burden of six healthcare-associated infections as being higher than that of diseases such as influenza, HIV/AIDS and tuberculosis together.

19 Oct 2016

New discovery helps explain why HIV infection increases risk for active tuberculosis

The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system.

18 Oct 2016

WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

New data published by the World Health Organization (WHO) in its 2016 Global Tuberculosis (TB) Report show that countries need to move much faster to prevent, detect and treat the disease if they are to meet global targets.

14 Oct 2016

Migrants pre-screened for TB pose negligible risk of infection, new study finds

Tuberculosis (TB) incidence in the UK has declined over the past 4 years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves.

13 Oct 2016

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

Botanical supplements are used by people around the world to treat a wide range of physical and mental ailments. Some of these botanical supplements have high levels of antioxidants, which may have some positive health effects for certain conditions.

12 Oct 2016

New research shows mother's milk helps baby to make copies of maternal immune cells

Scientists have long understood that mother's milk provides immune protection against some infectious agents through the transfer of antibodies, a process referred to as "passive immunity."

8 Oct 2016

Virginia Tech scientists solve structure of enzyme that deactivates important antibiotic

A popular antibiotic called rifampicin, used to treat tuberculosis, leprosy, and Legionnaire's disease, is becoming less effective as the bacteria that cause the diseases develop more resistance.

7 Oct 2016

Can vitamin D reduce asthma attacks? An interview with Professor Adrian Martineau

In the past vitamin D was just thought to be important in regulating calcium homeostasis and bone health as vitamin D deficiency is best known for causing rickets in children and osteomalacia in adults.

4 Oct 2016

Antibody protection may help control infection caused by TB bacteria

A study led by investigators from the Ragon Institute of MGH, MIT and Harvard finds evidence that antibody protection may help control infection with the bacteria that causes tuberculosis (TB).

4 Oct 2016

TB Alliance announces release of new TB medicines for Kenyan children

TB Alliance is proud to announce the launch of new medicines for childhood tuberculosis (TB) in Kenya, marking the first national roll out of these products.

30 Sep 2016

First generation antibiotics show promise for tuberculosis therapy

First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.

28 Sep 2016

GACD funds international research projects that aim to prevent, manage chronic lung diseases

Members of the Global Alliance for Chronic Diseases are funding more than thirteen international research projects into the prevention and management of chronic lung diseases.

28 Sep 2016

Smoke from indoor biomass fuel linked to COPD among rural women in Bangladesh

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death in the world.

26 Sep 2016

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

24 Sep 2016

Global study assesses countries on health-related Sustainable Development Goals

Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.

24 Sep 2016

World leaders at UN meeting commit to develop action plans on antimicrobial resistance

World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines.

24 Sep 2016

The UN General Assembly call for global action to tackle antimicrobial resistance

At a United Nations meeting held in New York, world leaders have warned against the very real and present threat antimicrobial resistance (AMR) poses to human and animal health, as well as sustainable food production and development.

22 Sep 2016

Crick researchers find promising target for new tuberculosis drugs

Scientists led by Dr Luiz Pedro Carvalho at the Francis Crick Institute in London have found a promising new target in the search for new tuberculosis drugs. In the process, they say they've proven the strengths of a new research technique called metabolomics.

20 Sep 2016

Tuberculosis News and Research

Latest Tuberculosis News and Research

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

Two leading non-profit organizations sign strategic affiliation to hasten drug development

Study estimates impact of six common healthcare-associated infections

New discovery helps explain why HIV infection increases risk for active tuberculosis

WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

Migrants pre-screened for TB pose negligible risk of infection, new study finds

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

New research shows mother's milk helps baby to make copies of maternal immune cells

Virginia Tech scientists solve structure of enzyme that deactivates important antibiotic

Can vitamin D reduce asthma attacks? An interview with Professor Adrian Martineau

Antibody protection may help control infection caused by TB bacteria

TB Alliance announces release of new TB medicines for Kenyan children

First generation antibiotics show promise for tuberculosis therapy

GACD funds international research projects that aim to prevent, manage chronic lung diseases

Smoke from indoor biomass fuel linked to COPD among rural women in Bangladesh

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Global study assesses countries on health-related Sustainable Development Goals

World leaders at UN meeting commit to develop action plans on antimicrobial resistance

The UN General Assembly call for global action to tackle antimicrobial resistance

Crick researchers find promising target for new tuberculosis drugs

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in